Swedish Orphan Biovitrum AB (publ)

BMV:SOBI N Stock Report

Market Cap: Mex$103.3b

Swedish Orphan Biovitrum Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

BMV:SOBI N Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
30 Aug 24BuyMex$19,571,426Guido OelkersIndividual70,000Mex$279.59
30 Aug 24BuyMex$23,632,776Torbjörn HallbergIndividual84,526Mex$279.59
30 Aug 24SellMex$164,569Katy MazibukoIndividual269Mex$611.78
30 Aug 24SellMex$918,388Katy MazibukoIndividual1,500Mex$612.26
28 Aug 24SellMex$41,952,363Guido OelkersIndividual70,000Mex$599.33
28 Aug 24SellMex$51,544,837Torbjörn HallbergIndividual84,526Mex$609.81
27 Aug 24SellMex$57,406,655Henrik StenqvistIndividual96,111Mex$597.30
27 Aug 24SellMex$60,319,723Guido OelkersIndividual100,000Mex$603.20
27 Aug 24SellMex$12,448,629Armin ReiningerIndividual20,452Mex$608.68
27 Aug 24SellMex$41,487,140Daniel RankinIndividual68,535Mex$606.93
12 Aug 24BuyMex$42,213Katy MazibukoIndividual86Mex$490.85
26 Jul 24BuyMex$24,930,134Guido OelkersIndividual100,000Mex$249.30
25 Jul 24SellMex$99,599,404Guido OelkersIndividual200,000Mex$498.55
25 Jul 24SellMex$27,502,857Christine WesstromIndividual55,250Mex$497.79
23 Jun 24SellMex$42,588,386Mahmood LadhaIndividual84,585Mex$503.50
04 Jun 24SellMex$63,608,002Duane BarnesIndividual132,401Mex$480.42
04 Jun 24SellMex$39,844,310Armin ReiningerIndividual83,219Mex$478.79
29 May 24SellMex$48,188,205Guido OelkersIndividual110,000Mex$438.07
28 May 24SellMex$48,092,530Guido OelkersIndividual110,000Mex$437.21
08 May 24BuyMex$15,648,712Daniel RankinIndividual49,344Mex$317.14
08 May 24SellMex$25,499,463Daniel RankinIndividual58,480Mex$439.51

Insider Trading Volume

Insider Buying: SOBI N insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of SOBI N?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders624,4150.211%
General Public25,008,6718.43%
Public Companies30,661,51210.3%
VC/PE Firms107,594,16536.3%
Institutions132,724,76244.7%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 85.77% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
36.3%
Investor AB (publ)
107,594,165Mex$37.5b0%4.0%
10.3%
AstraZeneca PLC
30,661,512Mex$10.7b0%no data
6.78%
AP Fonden 4
20,107,765Mex$7.0b0%1.9%
5.33%
State Street Global Advisors, Inc.
15,815,684Mex$5.5b0%0.02%
4.1%
JPMorgan Chase & Co, Private Banking and Investment Banking Investments
12,160,973Mex$4.2b0%0.09%
3.61%
BNY Mellon Asset Management
10,713,214Mex$3.7b0%0.04%
3.05%
Swedbank Robur Fonder AB
9,033,639Mex$3.1b0%0.18%
2.18%
The Vanguard Group, Inc.
6,455,458Mex$2.2b0.89%no data
2.04%
Handelsbanken Asset Management
6,053,900Mex$2.1b0%0.23%
1.8%
BlackRock, Inc.
5,330,277Mex$1.9b8.26%no data
1.69%
Polar Capital Holdings plc
5,022,187Mex$1.7b0%0.47%
1.52%
Norges Bank Investment Management
4,504,567Mex$1.6b0%0.01%
1.19%
Artisan Partners Limited Partnership
3,534,045Mex$1.2b-1.31%0.07%
0.71%
Nordea Investment Management AB
2,116,065Mex$736.8m0%0.03%
0.68%
SEB Investment Management AB
2,029,478Mex$706.6m0%0.1%
0.68%
Xact Kapitalförvaltning AB
2,003,965Mex$697.7m0%0.31%
0.62%
Brown Brothers Harriman & Co., Asset Management Arm
1,850,186Mex$644.2m0%0.24%
0.58%
Länsförsäkringar Fondförvaltning Aktiebolag
1,709,782Mex$595.3m0%0.17%
0.47%
SPP Fonder AB
1,390,216Mex$484.0m0%0.12%
0.45%
AP Fonden 2
1,346,524Mex$468.8m0%0.18%
0.35%
Third Swedish National Pension Fund
1,043,938Mex$363.5m0%0.12%
0.34%
Carnegie Fonder AB
1,000,001Mex$348.2m0%0.43%
0.33%
Fundlogic SAS
987,429Mex$343.8m0%1.03%
0.33%
Bessemer Investment Management LLC
970,342Mex$337.8m5.09%0.04%
0.32%
Amundi Asset Management
957,648Mex$333.4m-8.42%0.01%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/06/13 17:32
End of Day Share Price 2023/03/16 00:00
Earnings2023/03/31
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Swedish Orphan Biovitrum AB (publ) is covered by 30 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullABG Sundal Collier
Shirley ChenBarclays
Rosie TurnerBarclays